GENETIC VECTORS INC
NT 10-K, 1999-03-31
PHARMACEUTICAL PREPARATIONS
Previous: GRADALL INDUSTRIES INC, 10-K, 1999-03-31
Next: LIGHTBRIDGE INC, 10-Q/A, 1999-03-31



                      SECURITIES AND EXCHANGE COMMISSION
                            WASHINGTON, D.C. 20549

                                  FORM 12B-25

                                                  Commission File Number 0-21739

                          NOTIFICATION OF LATE FILING

    (Check One):  [X] Form 10-K   [ ] Form  11-K   [ ]  Form 20F   [ ] Form 10-Q

[ ] Form N-SAR

      For Period Ended:  DECEMBER 31, 1998

[ ] Transition Report on Form 10-K       [ ] Transition Report on Form 10-Q

[ ] Transition Report on Form 20-F       [ ] Transition Report on Form N-SAR

[ ] Transition Report on Form 11-K


      For the Transition Period Ended:
                                      ---------------------------------------
      READ ATTACHED  INSTRUCTION  SHEET BEFORE  PREPARING FORM.  PLEASE PRINT OR
TYPE.

      Nothing in this form shall be construed to imply that the  Commission  has
verified any information contained herein.

      If the  notification  relates to a portion of the  filing  checked  above,
identify the item(s) to which the notification relates:
                                                       -------------------------

                                    PART I
                             REGISTRANT INFORMATION

Full name of registrant: GENETIC VECTORS, INC.

Former name if applicable: N/A

Address of principal executive office (Street and number): 5201 N.W. 77th
Avenue, Suite 100 
City, state and zip code: Miami, Florida 33166


                                    PART II
                             RULE 12B-25 (b) AND (c)

      If the subject  report could not be filed without  unreasonable  effort or
expense  and  the  registrant  seeks  relief  pursuant  to Rule  12b-25(b),  the
following should be completed.
(Check appropriate box.)

[X]   (a) The reasons  described in  reasonable  detail in Part III of this form
      could not be eliminated without unreasonable effort or expense;

[X]   (b) The subject annual report,  semi-annual  report,  transition report on
      Form 10-K,  20-F,  11-K or Form N-SAR, or portion thereof will be filed on
      or before the 15th calendar day following the  prescribed due date; or the
      subject  quarterly  report or  transition  report on Form 10-Q, or portion
      thereof will be filed on or before the fifth  calendar day  following  the
      prescribed due date; and

[ ]   (c)   The  accountant's  statement  or  other  exhibit  required  by  Rule
      12b-25(c) has been attached if applicable.


<PAGE>

                                                                  FORM 12B-25


                                    PART III
                                    NARRATIVE

      State below in reasonable  detail the reasons why Form 10-K,  11-K,  10-Q,
N-SAR or the  transition  report  portion  thereof could not be filed within the
prescribed time period.
(Attach extra sheets if needed.)

      As reported in the  Registrant's  Form 10-QSB for the  three-month  period
ended  September 30, 1998,  the Registrant  had to raise  additional  capital in
order to continue  operations  beyond  November 1998.  The  Registrant  borrowed
$150,000 on November 2, 1998 which enabled the Registrant to continue operations
into December 1998 at which time the  Registrant  had to curtail  certain of its
business activities. The Registrant subsequently borrowed an additional $163,500
in January  1999 and another  $125,000 in March 1999.  As a result of a delay in
receiving the $125,000  loan,  the  Registrant  was forced to delay its year-end
audit. Due to this delay, the Registrant's audited financial statements will not
be ready until April 1999. The Registrant  respectfully requests an extension of
the filing date for its Annual Report on Form 10-KSB for the year ended December
31, 1998.


                                    PART IV
                                OTHER INFORMATION

      1.  Name and  telephone  number of  person  to  contact  in regard to this
notification:

            Mead M. McCabe, Jr.          (305)                      716-0000
            (Name)                    (Area code)             (Telephone number)

      2.  Have all other periodic  reports required under Section 13 or 15(d) of
the Securities  Exchange Act of 1934 or Section 30 of the Investment  Registrant
Act of 1940 during the  preceding 12 months or for such shorter  period that the
registrant was required to file such report(s) been filed?  If the answer is no,
identify report(s).

                                                [X]  Yes  [ ] No

      3. Is it anticipated that any significant  change in results of operations
from the corresponding  period for the last fiscal year will be reflected by the
earnings statements to be included in the subject report or portion thereof?

                                                [X]  Yes  [  ] No

      If so: attach an explanation of the anticipated  change,  both narratively
and  quantitatively,  and, if  appropriate,  state the reasons why a  reasonable
estimate of the results cannot be made.

      See Attachment.



                                      -2-
<PAGE>
                                                                  FORM 12B-25



                              GENETIC VECTORS, INC.
                  (Name of registrant as specified in charter)

Has  caused  this  notification  to be signed on its  behalf by the  undersigned
thereunto duly authorized.




Date:  March 31, 1998            By:  /s/ Mead M. McCabe, Jr.           
                                      ----------------------------------
                                          Mead M. McCabe, Jr., President


         INSTRUCTION.  The form may be signed  by an  executive  officer  of the
registrant or by any other duly authorized representative. The name and title of
the person signing the form shall be typed or printed beneath the signature.  If
the  statement  is  signed  on  behalf  of  the   registrant  by  an  authorized
representative   (other   than   an   executive   officer),   evidence   of  the
representative's  authority to sign on behalf of the  registrant  shall be filed
with the form.

                                    ATTENTION

      Intentional misstatements or omissions of fact constitute Federal criminal
violations (see 18 U.S.C. 1001).


                              GENERAL INSTRUCTIONS

      1.  This  form is  required  by  Rule  12b-25  of the  General  Rules  and
Regulations under the Securities Exchange Act of 1934.

      2.  One  signed  original  and  four  confirmed  copies  of this  form and
amendments  thereto must be completed and filed with the Securities and Exchange
Commission,  Washington,  DC 20549,  in accordance  with Rule 0-3 of the General
Rules and Regulations under the Act. The information  contained in or filed with
the form will be made a matter of the public record in the Commission files.

      3. A manually  signed  copy of the form and  amendments  thereto  shall be
filed with each national securities exchange on which any class of securities of
the registrant is registered.

      4. Amendments to the  notifications  must also be filed on Form 12b-25 but
need not restate information that has been correctly  furnished.  The form shall
be clearly identified as an amended notification.

      5.  ELECTRONIC  FILERS.  This form shall not be used by electronic  filers
unable to timely file a report  solely due to  electronic  difficulties.  Filers
unable to submit a report within the time period  prescribed due to difficulties
in  electronic  filing  should  comply  with  either  Rule  201 or  Rule  202 of
Regulation  S-T or apply for an adjustment in filing date pursuant to Rule 13(b)
of Regulation S-T.





                                      -3-

<PAGE>
                                                                  FORM 12B-25


                                   ATTACHMENT
                       (CHANGES IN RESULTS OF OPERATIONS)


      The  Registrant  expects  to  report a  significant  decrease  in its cash
position  from the prior fiscal year. As reported in Form 10-QSB for the quarter
ended  September 30, 1998,  the  Registrant had projected that the proceeds from
its initial  public  offering,  which closed on December  26,  1996,  would last
through  November  1998.  As of the date hereof,  the  Registrant  has raised an
aggregate of $438,500 in additional  funds which the Registrant  expects to last
through  March 1999.  Significant  additional  capital will be necessary for the
Registrant to continue its business activities beyond March 1999. The Registrant
expects to report cash and cash equivalents  equal to approximately  $156,000 on
December 31, 1998 compared to  approximately  $2.1 million on December 31, 1997.
Without  additional  capital,  the Registrant  will need to curtail or cease its
business activities until additional capital can be obtained, if at all.




















                                      -4-


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission